REHOVOT, Israel, Oct. 31, 2022 /PRNewswire/ — Sequentify announced its collaboration with Yeda, the commercial arm of the Weizmann Institute of Science (WIS) and NIH, as part of a grant to sequence over 6,000 patients using the Sequentify Myeloid NGS panel, offering cost-effective, high throughput NGS sequencing at scale.
Read more here.
![[Diagnostic Robotics in Calcalist] “Being an entrepreneur is like jumping off a cliff and making your parachute as you are falling”](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
